(Q43686202)

English

Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension

scientific article published in August 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

Larsson LI

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1439-1444

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

24-hour (nyctohemeral) and sleep-related variations of intraocular pressure in healthy white individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of the diurnal tension variations in normal and glaucomatous eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty-four hourly variations in the inflow of the aqueous humour

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of withdrawal of timolol in chronically treated glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Aqueous flow in open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Circadian intraocular pressure variation with beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 24 hour control with Timoptic 0.5% and Timoptic-XE 0.5% in exfoliation and primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Individual variability in the diurnal intraocular pressure curve

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Diurnal variation of intraocular pressure and the overriding effects of sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900605-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(01)00605-4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43686202&oldid=2102505186"